Q4 EARNINGS: Getinge solid; Illumina, St Jude as expected
This article was originally published in Clinica
Executive Summary
Not long after swapping its CEO, Getinge has reported a “solid” fourth quarter. What’s more, its 2015 outlooks “suggests a sustainable recovery in sales/profitability,” said Jefferies analyst Martin Brunninger.